New Delhi: Drug firm Granules India on Monday said it has received approval from the US health regulator to market a generic medication for attention deficit hyperactivity disorder. Granules ...

Jan 23 (Reuters) - Paracetamol maker Granules India reported a 28% jump in third-quarter profit on Friday, driven by strong demand in its key European and North American markets. Consolidated profit ...

Granules India Ltd on Thursday said its arm Granules Pharmaceuticals, Inc has received tentative approval from the US health regulator for its generic amphetamine extended-release tablets indicated ...

Priyanka Chigurupati, Executive Director of Granules India, said that funds raised through warrants and primary issuance will be used to strengthen the balance sheet and support growth in complex ...

May 28 (Reuters) - Granules India (GRAN.NS), opens new tab reported a drop in fourth-quarter adjusted profit on Wednesday, hurt by weak pricing and stiff competition in its key European and North ...

Aug 12 (Reuters) - Paracetamol maker Granules India (GRAN.NS), opens new tab reported a first-quarter profit fall on Tuesday, as a supply backlog hit sales. Consolidated profit fell 16.3% to 1.13 ...

Consolidated profit rose to 1.5 billion rupees ($16.3 million) in the quarter ended December 31, compared with 1.18 billion rupees in the same period ...